The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Want to come back to EIS would I be right in thinking that not only can employees not participate but also financial institutions so neither could Schroders. Also anyone up to speed on Carbon credits. Who would issue these credits to Atome and can they be sold anywhere
Great find I also believe that Atome is looking very seriously a shipping ammonium nitrate to the UK in size. The UK 's net zero target would be strongly enhanced by this and possibly be subsidized by the government who knows
There has in recent months been an increase in the mention of the UK and Ireland with regard to product placement which I suspect would arise from the second project in Paraguay as they mention the production of ammonium nitrate as opposed to CAN ( easier to transport) so wonder if as a result EIS status might be then beneficial .
Thoughts?
the whole placement and timing smells somewhat. do current investors get to take advantage of eis x (twitter) says those who participated in last fund raise. if you bought in the open market after the fund raise what's the score?.
correct me if i am wrong but to build out these 3 projects is close to 1 billion $$$, there is a cap on annual investment for eis which quite frankly is a **** in the wind in relation to monies required.
so eis and project finance don't seem to me to add up. the company has enough money to get to fid, if successful stock should be worth £1.50 + a new fund raise at some point to add working capital say 5m will happen to see out the 3 build outs.
I have to confess I do not fully understand the potential consequences of this anyone have an idea of why the company has applied for this. As I understand the company is fully funded to FID with project finance looking achievable with no need for stock dilution any accountants out there?